Leslie Gold
Tissue Regeneration Sciences, Inc (TRS)
Affiliations
New York University
Technologies
Therapeutic
Indication
Basic Research
Clinical Research
Dermatology
Drug Discovery
Fibrosis
Personalized Medicine
Regenerative Medicine
Tissue Regeneration Sciences, Inc (TRS) is a start-up biotechnology company formed on the discovery of calreticulin (CRT), as a novel biotherapeutic that has unique, diverse and broad ranging tissue regenerative qualities that will be developed for different indications including chronic wound healing, epidermal appendage (hair follicle) neogenesis, improving the cosmetic architecture of the skin, and healing of ophthalmic ulcers.
Program of
Initiated by
